11,828 Shares in Revvity Inc. $RVTY Purchased by Rakuten Investment Management Inc.

Rakuten Investment Management Inc. purchased a new stake in Revvity Inc. (NYSE:RVTY) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 11,828 shares of the company’s stock, valued at approximately $1,315,000.

Several other hedge funds have also bought and sold shares of RVTY. Bank of New York Mellon Corp acquired a new stake in Revvity during the second quarter valued at $78,766,000. California State Teachers Retirement System raised its position in shares of Revvity by 19.8% in the first quarter. California State Teachers Retirement System now owns 133,809 shares of the company’s stock worth $11,723,000 after acquiring an additional 22,075 shares during the period. Corient Private Wealth LLC raised its position in shares of Revvity by 985.0% in the fourth quarter. Corient Private Wealth LLC now owns 126,568 shares of the company’s stock worth $12,245,000 after acquiring an additional 114,903 shares during the period. Tocqueville Asset Management L.P. purchased a new stake in shares of Revvity during the 2nd quarter worth about $4,791,000. Finally, Diamond Hill Capital Management Inc. grew its position in shares of Revvity by 6.3% during the 4th quarter. Diamond Hill Capital Management Inc. now owns 426,899 shares of the company’s stock valued at $41,302,000 after acquiring an additional 25,233 shares during the period. Hedge funds and other institutional investors own 86.65% of the company’s stock.

Revvity Price Performance

NYSE:RVTY opened at $128.88 on Monday. Revvity Inc. has a one year low of $81.22 and a one year high of $130.07. The stock has a market cap of $14.38 billion, a PE ratio of 61.37, a P/E/G ratio of 2.34 and a beta of 1.07. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.50 and a current ratio of 1.80. The stock has a 50 day moving average price of $114.09 and a 200 day moving average price of $101.20.

Revvity (NYSE:RVTY) last released its quarterly earnings data on Tuesday, August 4th. The company reported $1.41 earnings per share for the quarter, topping analysts’ consensus estimates of $1.21 by $0.20. The company had revenue of $729.69 million for the quarter, compared to analyst estimates of $702.96 million. Revvity had a return on equity of 8.34% and a net margin of 8.16%.The firm’s revenue for the quarter was down 1.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.18 earnings per share. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS. Equities research analysts expect that Revvity Inc. will post 5.36 EPS for the current fiscal year.

Revvity Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 13th. Investors of record on Friday, October 23rd will be issued a $0.07 dividend. The ex-dividend date of this dividend is Friday, October 23rd. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.2%. Revvity’s dividend payout ratio is currently 13.33%.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on RVTY. Evercore restated an “outperform” rating on shares of Revvity in a research report on Wednesday, August 5th. Robert W. Baird set a $117.00 price objective on Revvity in a research note on Wednesday, May 6th. JPMorgan Chase & Co. decreased their price objective on Revvity from $96.00 to $90.00 and set a “neutral” rating on the stock in a report on Wednesday, May 6th. Barclays lifted their target price on shares of Revvity from $95.00 to $105.00 and gave the stock an “equal weight” rating in a research note on Thursday, May 7th. Finally, Stifel Nicolaus reduced their target price on shares of Revvity from $110.00 to $100.00 and set a “hold” rating for the company in a research report on Wednesday, May 6th. Three investment analysts have rated the stock with a Buy rating and twelve have assigned a Hold rating to the company. According to data from MarketBeat, Revvity has an average rating of “Hold” and an average price target of $108.36.

About Revvity

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.